Literature DB >> 12438742

Isolation and characterization of a human novel RAB (RAB39B) gene.

H Cheng1, Y Ma, X Ni, M Jiang, L Guo, K Ying, Y Xie, Y Mao.   

Abstract

Rab proteins are small-molecular-weight GTPases that control vesicular trafficking in eukaryotic cells. During the large-scale sequencing analysis of a human fetal brain cDNA library, we isolated a cDNA clone encoding a novel Rab protein, which showed 74.2% identity with previously isolated Rab39A at the amino acid level. RAB39B was expressed in a variety of human tissues and located in human chromosome Xq28. It consisted of two exons spanning 3764 bp of human genomic DNA. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12438742     DOI： 10.1159/000064047

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN： 1424-8581            Impact factor:   1.636


  14 in total

Review 1.  DENN domain proteins: regulators of Rab GTPases.

Authors:  Andrea L Marat; Hatem Dokainish; Peter S McPherson
Journal:  J Biol Chem       Date:  2011-02-17       Impact factor: 5.157

2.  Probing the virus host interaction in high containment: an approach using pooled short hairpin RNA.

Authors:  Claire Marie Filone; Ken Dower; Glenn S Cowley; Lisa E Hensley; John H Connor
Journal:  Assay Drug Dev Technol       Date:  2015-02-03       Impact factor: 1.738

Review 3.  CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.

Authors:  Fatemeh Safari; Gholamreza Hatam; Abbas Behzad Behbahani; Vahid Rezaei; Mazyar Barekati-Mowahed; Peyman Petramfar; Farzaneh Khademi
Journal:  Cell Mol Neurobiol       Date:  2019-11-26       Impact factor: 5.046

Review 4.  Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.

Authors:  Marcellus J Banworth; Guangpu Li
Journal:  Small GTPases       Date:  2017-12-28

5.  Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.

Authors:  Gabrielle R Wilson; Joe C H Sim; Catriona McLean; Maila Giannandrea; Charles A Galea; Jessica R Riseley; Sarah E M Stephenson; Elizabeth Fitzpatrick; Stefan A Haas; Kate Pope; Kirk J Hogan; Ronald G Gregg; Catherine J Bromhead; David S Wargowski; Christopher H Lawrence; Paul A James; Andrew Churchyard; Yujing Gao; Dean G Phelan; Greta Gillies; Nicholas Salce; Lynn Stanford; Ashley P L Marsh; Maria L Mignogna; Susan J Hayflick; Richard J Leventer; Martin B Delatycki; George D Mellick; Vera M Kalscheuer; Patrizia D'Adamo; Melanie Bahlo; David J Amor; Paul J Lockhart
Journal:  Am J Hum Genet       Date:  2014-11-26       Impact factor: 11.025

Review 6.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

7.  A proteomics approach to decipher the molecular nature of planarian stem cells.

Authors:  Enrique Fernández-Taboada; Gustavo Rodríguez-Esteban; Emili Saló; Josep F Abril
Journal:  BMC Genomics       Date:  2011-02-28       Impact factor: 3.969

Review 8.  Human diseases associated with form and function of the Golgi complex.

Authors:  Mariana G Bexiga; Jeremy C Simpson
Journal:  Int J Mol Sci       Date:  2013-09-10       Impact factor: 5.923

9.  Rab39a binds caspase-1 and is required for caspase-1-dependent interleukin-1beta secretion.

Authors:  Christine E Becker; Emma M Creagh; Luke A J O'Neill
Journal:  J Biol Chem       Date:  2009-10-15       Impact factor: 5.157

10.  Loss-of-function mutations in RAB39B are associated with typical early-onset Parkinson disease.

Authors:  Suzanne Lesage; Jose Bras; Florence Cormier-Dequaire; Christel Condroyer; Aude Nicolas; Lee Darwent; Rita Guerreiro; Elisa Majounie; Monica Federoff; Peter Heutink; Nicholas W Wood; Thomas Gasser; John Hardy; François Tison; Andrew Singleton; Alexis Brice
Journal:  Neurol Genet       Date:  2015-06-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.